Drug Type Therapeutic vaccine, Dendritic cell vaccine |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Melanoma recurrent | Phase 2 | United States | 01 Jul 2000 | |
| Melanoma, Cutaneous Malignant | Phase 2 | United States | 01 Jul 2000 | |
| Metastatic melanoma | Phase 2 | United States | 01 Jul 2000 | |
| Renal Cell Carcinoma | Phase 1 | United States | 01 Nov 2001 |





